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Resumo 
Nos procedimentos cirúrgicos, as drogas de bloqueio neuromuscular são usadas para 
facilitar a intubação traqueal, proporcionar relaxamento muscular e imobilidade, e auxiliar a 
ventilação mecânica. Além disso, o anestesista deve assegurar-se que o paciente saia da sala 
de operações com a força muscular recuperada, especificamente nos músculos respiratórios e 
nas vias aéreas superiores, de modo a manter uma respiração autónoma. Para atingir este 
objetivo, duas estratégias podem ser adotadas: titular os agentes bloqueadores 
neuromusculares de modo a que nenhum efeito residual permaneça no final da cirurgia, ou pela 
administração de uma droga de ação inversa, que acelera a recuperação do paciente. Em ambos 
os casos deve ser efetuada uma monitorização cuidadosa para garantir uma avaliação correta 
da extensão do bloqueio neuromuscular. Entre os diferentes tipos de monitorização, o mais 
preciso baseia-se na avaliação quantitativa e objetiva das respostas evocadas mecanicamente, 
desencadeadas pela estimulação elétrica fornecida por um estimulador de nervos periféricos. 
Para o efeito, são aplicados padrões de estimulação e as respetivas respostas são registadas e 
avaliadas. 
Mesmo não sendo habitualmente efetuado, monitorizar os efeitos das drogas de bloqueio 
neuromuscular precisa ser realizado rotineiramente. Está comprovado que a monitorização 
neuromuscular pode auxiliar no diagnóstico de relaxamento esquelético inadequado durante a 
cirurgia e recuperação insuficiente após a cirurgia. Além disso, pode reduzir a incidência de 
complicações na unidade de recuperação pós-anestésica causada pelo fenómeno da curarização 
residual pós-operatória. Esse bloqueio residual é de grande preocupação clínica, pois aumenta 
o risco de complicações pulmonares, levando a um aumento da morbidade e mortalidade. 
Este projeto faz parte de uma abordagem inovadora de desenvolvimento de um estimulador 
capaz de fornecer informação mais segura e fiável do bloqueio neuromuscular, através da 
criação de padrões de estimulação personalizados, permitindo um bloqueio neuromuscular 
individualizado e mais adequado durante os procedimentos médicos. Para tal, foi desenvolvido 
um circuito eletrónico e uma interface feita em LabVIEW. A interface permite ao utilizador 
programar o sistema eletrónico de modo a obter-se um estímulo com os atributos pretendidos. 
O sistema corretamente transmite um sinal com corrente controlável e com as características 
de onda desejadas. A tensão do estímulo necessária para uma estimulação apropriada seria 
conseguida a partir do uso de uma fonte de corrente adequada. 
 
Palavras-chave: bloqueio neuromuscular, estimulador de nervo periférico, resposta evocada, 
eletrónica. 
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Abstract 
In surgical procedures, neuromuscular blocking drugs are used to facilitate tracheal 
intubation, to provide muscle relaxation and immobility, and to help mechanical ventilation. 
Furthermore, the anaesthetist should ensure that the patient leaves the operating room with 
unimpaired muscle strength, specifically respiratory and upper airway muscles recovery, in 
order to restore autonomous patient’s breathing. To achieve this goal, two strategies can be 
adopted: to titrate neuromuscular blocking agents so that no residual effect remains at the end 
of surgery or by administration of a reversal drug, accelerating recovery. In both cases, a 
precise monitoring should be undertaken to guarantee a correct assessment of neuromuscular 
blockade extent. Among different types of monitoring, the most accurate relies on a 
quantitative and objective evaluation of the mechanically evoked responses triggered by 
electrical stimulation, delivered from a peripheral nerve stimulator. For that, few stimulation 
patterns are applied and the mechanically evoked responses are recorded and evaluated.  
Even though not consistently done, monitoring the effects of the neuromuscular blocking 
drugs need to be routinely performed. It is proved that neuromuscular monitoring can help in 
the diagnosis of inadequate skeletal relaxation during surgery and insufficient recovery after 
surgery. Also, it can reduce the incidence of complications in the post anaesthesia care unit 
caused by post-operative residual curarization phenomenon. This residual blockade is of great 
clinical concern since rises the risk of pulmonary complications leading to an increase in 
morbidity and mortality.  
This project is an innovative approach of a stimulator able to provide a safer and more 
reliable evaluation of neuromuscular blockade by stimulating patients according to individual 
responses, allowing a personalized and more adequate neuromuscular blockade during medical 
procedures. For this purpose, it was created an electronic circuit and an interface developed 
in LabVIEW. The interface allows the user to programme the electronic system in order to 
obtain output stimulus with the intended attributes. The system successfully outputs a signal 
with controllable electric current, and with the chosen waveform characteristics. A correct 
voltage required for an appropriate stimulation could be achieved using a customized current 
source. 
 
 
 
Keywords: Neuromuscular blockade, peripheral nerve stimulator, evoked response, 
electronics. 
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Chapter 1: Introduction 
1.1 - Background: Neuromuscular Transmission 
The central nervous system is the part of the nervous system that comprises the brain and 
the spinal cord. Its primary component is the neuron, or nerve cell. A neuron is an electrically 
excitable cell able to be stimulated and to transmit information through electrical and 
chemical signals by conducting impulses. The typical structure of a neurons consists of a cell 
body, dendrites and an axon. Impulses are carried along one or more dendrites to the cell body 
and is the axon that carries the impulse away from the cell body. It is in the synapse that a 
neuron communicates electrical or chemically with another neuron or target efferent cell 
through a phenomenon called neuromuscular transmission [1].  
Motor neurons are nerve cells that are responsible for transmitting signals from the spinal 
cord to an effector (muscle or glandular) tissue [2]. They innervate the body muscles and thus 
are involved in all voluntary and involuntary movements such as speaking, walking, breathing 
and swallowing [3]. Motor neuron cell bodies lie in the anterior horn of the spinal cord or in 
the corresponding motor nuclei of cranial nerves, and axons are projected to or outside of the 
spinal cord. Somatic motor neurons are motor neurons originated in the central nervous system 
whose axons are projected to skeletal muscles, enabling its contraction [2].  
Skeletal muscle fibres are fast conducting fibres since are innervated by somatic motor 
neurons – generally myelinated – which provides better insulation and more rapid conduction 
of impulses.  
A motor unit comprises all muscle fibres that are innervated by a single motor neuron and 
the motor neuron itself. Each individual motor neuron innervates several muscle fibres by its 
axonal terminals. It is the neuromuscular junction (NMJ) the specialized synapse that connects 
the motor neuron with the target skeletal muscle fibre [4]. 
The anatomy of the NMJ consists of a prejunctional motor nerve ending – presynaptic region 
– separated from the highly folded postjunctional membrane of the skeletal muscle – motor 
endplate – by a synaptic cleft. In the pre and postjunctional sites are located the nicotinic 
acetylcholine receptors (nAChRs). The nAChR has a rosette shape made up of five subunits (2-
α, 1-β, 1-ɣ and 1-δ) arranged such that a channel is formed, and allows the flow of ions along 
a concentration gradient across cell membranes – the basis of normal neuromuscular 
transmission [5].  
The neuromuscular transmission is initiated by arrival of an impulse at the motor nerve 
terminal. In the motor nerve terminal is synthesized, stored in vesicles and released the 
neurotransmitter molecules – acetylcholine (ACh). Vesicles spontaneously empty into the 
synaptic gap. However, this spontaneous release is not sufficient to trigger muscle contraction, 
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until the arrival of action potentials at the motor neuron. In this case, an influx of Ca2+ is 
triggered into the nerve ending and several hundred vesicles synchronously release their ACh 
into the synaptic cleft. If ACh binds to both of the nAChR α-subunits on postjunctional 
membranes, the nAChR ion channel opens, allowing the passage of Na+ and Ca2+ into and K+ 
ions out of the muscle cell. This change in permeability due to ionic changes causes a decrease 
in the transmembrane potential from about -90mV to -45mV, at which point a propagated 
action potential spreads over the surfaces of skeletal muscle fibres and leads to muscular 
contraction. To prevent sustained depolarization, the membrane permeability is restored 
(repolarization) by the action of the enzyme acetylcholinesterase (AChE) which rapidly 
hydrolyses ACh.  
The mechanism of neuromuscular transmission is represented in Figure 1.1. 
 
Figure 1.1 - Physiology of neuromuscular transmission. (a) At the NMJ, where calcium influx causes 
release of ACh. ACh then binds to the postsynaptic nAChR at the motor endplate. (b) Binding of two ACh 
olecules opens up the ion channel leading to an action potential, which causes muscle contraction [6].  
 
One of the primary anaesthetic goals for the intraoperative management of surgical 
patients is akinesia (loss of ability to move muscles voluntarily). When patients are 
pharmacologically unable to move, surgical exposure is improved. There are a number of 
medications and combinations of medications that can cause akinesia. The most common drugs 
used in the operating room are the muscle relaxants or neuromuscular blockers. 
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1.2 - Mechanism of Action of Neuromuscular Blocking Drugs 
Neuromuscular blockers induce a state of pharmacologic paralysis by interfering with the 
normal processes of neurotransmitter–receptor interaction at the NMJ [6]. There are two main 
types of neuromuscular blockers: depolarizing and nondepolarizing. 
1.3.1 - Depolarizing neuromuscular blocking agents 
 
Depolarizing NMBDs mimic the effect of ACh and therefore can be considered agonists, 
although they block neurotransmission after an initial stimulation [7]. In fact, the only 
depolarizing NMBD clinically used – succinylcholine – is composed by two ACh molecules 
bounded together. Succinylcholine molecule binds to the two α-subunits of a nAChR, and 
depolarization occurs, inducing the same effect as ACh at the nAChR. When succinylcholine 
binds to nAChR, the voltage-sensitive sodium channels sense membrane depolarization and 
open, passing the current. It leads to endplate depolarization. The channels thereafter close 
and remain inactivated [8]. To reactivate these channels, the membrane potential must be 
reset.  The response to ACh takes only milliseconds due to its rapid hydrolysis by AChE within 
the synaptic cleft, reverting the endplate to its resting state. However, succinylcholine is not 
metabolised by the AChE, so the ACh receptors activation is prolonged [8]. Depolarizing NMBDs 
are not removed from the synaptic cleft until they are eliminated from the plasma, being the 
duration of block determined by the time required to clear them from the body. Since 
depolarizing NMBDs cause continuous depolarization of the endplate, a quick change from 
excitation and muscle contraction to block of transmission is observed. 
 
1.3.2 - Non-depolarizing neuromuscular blocking agents 
 
Non-depolarizing NMBDs antagonize the action of ACh by competitively preventing the 
binding of ACh to the postsynaptic nAChR. Unlike depolarizing NMBDs, non-depolarizing NMBDs 
do not produce conformational changes in the receptor [8]. If a single molecule of non-
depolarizing NMBD binds to one α-subunit of a nAChR, the voltage-sensitive sodium channel 
cannot open, preventing the depolarization of the channel [7]. The binding of antagonists to 
the receptors is dynamic, that is, if the concentration of ACh is increased, it has a higher chance 
of occupying the two α-subunits of the receptors rather than the antagonist. With non-
depolarizing NMBD, there is a gradual reduction in endplate potential until it is below the 
threshold to trigger a propagation action potential to produce muscle contraction. 
Neuromuscular blockade (NMB) only becomes evident when 70-80% of receptors are occupied 
by non-depolarizing NMBD molecules [8]. To achieve a complete NMB, at least 92% of receptors 
must be occupied. Non-depolarizing NMBDs - Pancuronim, Vecuronium, Rocuronium, 
Atracurium, Cisatracurium and Mivacurium – are clinically chosen according to factors such as 
the difference in onset, duration of action, rate of recovery, metabolism and clearance [9] 
[10]. 
An adequate recovery from NMB is crucial to restore motor laryngeal reflexes, respiratory 
response and motor function [10][11].  
However, patients receiving NMBDs may be at risk of postoperative residual curarization 
(PORC). This residual blockade related phenomenon is of great clinical concern and might occur 
due to an excessive neuromuscular blocking drugs dosage, early administration of reversal 
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drugs, or abnormal response of the patient. PORC is associated to impairment of the respiratory 
response, and dysfunction of the pharynx and upper oesophagus resulting in an increased risk 
of postoperative pulmonary complications, and consequently an increased postoperative 
morbidity and mortality.  
 
There are several ways to reduce the risk of developing residual blockade when using 
NMBDs. One approach is to wait for spontaneous recovery by diffusion of NMBDs away from 
NMJ, combined with clinical evaluation of neuromuscular function recovery. Other method is 
the acceleration of recovery through a systematic pharmacologic reversal of the NMB by use of 
reversal agents [10][12]. 
 
1.3.3 - Neuromuscular blockade reversal agents 
 
Non-depolarizing NMB is reversed by using cholinesterase inhibitors. These agents act 
indirectly by inactivating the AChE in the synaptic cleft of NMJ, increasing the competitive 
position of ACh [11]. This position is majorly influenced by two factors: the concentration of 
ACh and the period of time ACh remains in the cleft. Increasing the number of ACh molecules 
in the synaptic cleft raises the probability of ACh to occupy the recognition sites of the 
receptor, restoring NMJ transmission. It also enables unoccupied receptors to become occupied 
with ACh because only about 500,000 of 5 million existing receptors are activated by a single 
nerve impulse, remaining a considerable number of unused receptors. The second factor, 
length of time ACh remains in the cleft, is essential because prolonging the time during which 
ACh is in the synaptic junction allows ACh to more effectively bind to the receptor after the 
non-depolarizing NMBA dissociate from it. That is, the AChE acts so quickly on ACh that most 
of molecules are destroyed before any substantial amount of non-depolarizing neuromuscular 
blocking agents (NMBAs) have dissociated from the receptors so that ACh molecules can bind 
to them [7].  
Since depolarizing NMBAs are eliminated from the NMJ by diffusion, reversal agents do not 
exert any effect on the NMB provoked by these drugs [6]. Sugammadex, Neostigmine and 
Edrophonium are the most clinically used AChE inhibitors, which reversibly attach to AChEs 
[13].  
 
The most reliable method to monitor the pharmacologic effects of NMBDs is by evaluation 
of the mechanically evoked responses produced by electrical stimulation delivered from a 
peripheral nerve stimulator [9]. 
1.3 - Nerve Stimulation 
The clinical basis of nerve stimulation involves applying an electrical stimulus directly over 
a motor nerve and monitoring the associated response. This motor response can be used to 
determine the degree of NMB, to judge spontaneous recovery from an NMBD-induced blockade, 
to ensure ideal intubating conditions, to maintain adequate paralysis during critical operative 
periods, and to monitor the return of function so that extubating criteria can be met [6][9]. 
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1.4.1 – Physiological Principles of Nerve Stimulation 
 
Neuromuscular function, influenced by the effects of NMBAs, is monitored by assessing the 
mechanically evoked responses of the muscle to a supramaximal stimulation (i.e. one in which 
all axons in the nerve are made to discharge) [14]. The stimulation of a muscle fibre obeys to 
the all-or-none law which states that a muscle fibre responses to a stimulus when it exceeds 
the threshold potential. However, when the whole muscle is stimulated, the response is 
determined by the number of muscle fibres stimulated. That is, if the nerve is stimulated with 
an appropriate intensity, all the muscle fibres, innervated by that nerve, contract and a 
maximal response is generated [15].  
After the administration of NMBDs, the response of muscles decreases attending to the 
number of nerve fibres blocked. When a continuous stimulation is applied, the degree of 
reduction in response discloses the extent of NMB. 
To monitor the effects of NMBDs, mechanically evoked responses are assessed, being 
obtained after the application of patterns of nerve stimulation.  
 
1.4.2 - Patterns of Nerve Stimulation 
 
For evaluation of neuromuscular function the most commonly used patterns of electrical 
nerve stimulation are Single twitch, Train-of-four, Tetanic, Post-tetanic count and Double burst 
stimulation.  
 
a) Single Twitch 
 
The Single twitch is a single supramaximal electrical stimulus applied to the target motor 
nerve; the subsequent motor response is evaluated. The frequency range with which single 
stimulus is applied is 0.1-1 Hz. The fatigue of muscle response – fade – can be observed after 
high-frequency stimulation (higher than 0.15 Hz). The fade phenomenon occurring in non-
depolarizing NMB is due to the inhibition of presynaptic ACh release [16]. The higher the 
stimulation frequency is, the more pronounced is the fade, overemphasizing NMB. Therefore, 
the most common frequency applied is 0.1 Hz [3]. The ratio of the evoked response and the 
response before muscle relaxation – T1% - gives an indication of the NMB extent [17]. In both 
depolarizing and non-depolarizing NMBs there is a progressive decay in twitch height. This 
stimulation mode only presents clinical relevance when used as a component of TOF or PTC. 
Figure 1.2 shows a representation of a single twitch at a frequency of 1 Hz. 
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b) Train-of-four stimulation 
 
The Train-of-four stimulation (TOF) is based on the concept that ACh is depleted by 
successive stimulations. This method relies on four electrical stimuli given at a frequency of 
2Hz. These four twitches are sufficient because following stimulation fails to promote the 
release of additional ACh. Repeated TOF stimulation can lead to a progressive fade of the motor 
response, existing or not muscle blockade (i.e. 2Hz is above the threshold of 0.15 Hz, as 
previously explained in Single twitch method). To avoid this phenomenon from happening and 
falsifying the analysis of the NMB, an interval between two TOF series must be established to 
allow the regeneration of the neuromuscular endplate. The optimal interval between two 
successive TOF series is 10-20s [9].  
The degree of fade, or TOF ratio, indicates the extent of the NMB and is given by the 
quotient of the amplitude of the fourth response (T4) and  the amplitude of the first response 
(T1) [18].  
Once applied TOF stimulation in an unrelaxed patient, all four responses are detected and 
have the same intensity (TOF ratio equal to 1) [3].  
As the administration of non-depolarizing NMBDs takes effect on the NMJ, is produced a 
decrease in magnitude of the first twitch compared with a pre-relaxant stimulus. Also, all four 
stimulatory responses exhibit  fade (due to muscle fatigue) starting with the fourth twitch until 
no responses are detected [9]. The degree of receptor occupancy is indicated by the number 
of provoked twitches, making it easier to set the proper time for intubation. The loss of T4, 
T3, T2 and T1 responses corresponds to 75%, 80%, 90% and 100% receptors occupancy, 
respectively. During recovery of neuromuscular function, twitches appear in the reverse order 
[17]. 
Intraoperatively, the extent of NMB can be accessed by counting the detectable responses 
after TOF stimulation – TOF count. If one or two of the four responses are detectable, the 
degree of relaxation will be acceptable for the majority of surgical procedures. As the depth 
of NMB is related with the TOF count, the reappearance of responses is an indicator to evaluate 
the time point for NMBD reinjection. Nonetheless, TOF count allows to infer whether the 
spontaneous recovery from NMB is sufficient to reverse the residual blockade with reversal 
drugs. The recovery begins as soon as all the four responses become discernible again [3].  
  
Since depolarizing drugs have a different acting mode in NMB, there is no fade in response 
to TOF stimulation (TOF ratio equal to 1), and all four responses are equally reduced. Moreover, 
0,2 ms 
1 s 
Figure 1.2 – Single twitch pattern. 
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all TOF responses vanish at the same time, meaning that TOF count is equal to zero or four. In 
this way, TOF is not suitable for describing a depolarization blockade [16]. 
Figure 1.3 contains a representation of the TOF pattern at a frequency of 1 Hz.  
 
c) Double-burst stimulation 
 
The Double burst stimulation (DBS) consists of two short bursts of three stimulus (DBS 3-3), 
or one burst of two stimulus followed by one of three stimulus (DBS 2-3), or one burst of three 
stimulus followed by one of two stimulus (DBS 3-2), both bursts at 50 Hz, separated by 750 ms 
[9][17]. When DBS is applied to the unblocked NMJ, this stimulation pattern induces two short 
muscle contractions. In a patient with a non-depolarizing NMB, DBS induces a weaker second 
response. A good correlation between the ratio of second burst to first burst and TOF ratio has 
been reported [19]. Moreover, has been demonstrated that DBS is more sensitive than TOF in 
the manual detection of residual NMB. That is, manual detection of fade is improved with DBS 
stimulation when TOF ratio is less than 0.4. However, for a TOF ratio greater than 0.7 it is not 
ensured that a manual assessment of DBS allows a reliable detection of fade [20]. For 
monitoring depolarizing blockade, DBS offers no advantages over TOF [3]. 
Figures 1.4, 1.5 and 1.6 displays a representation of DBS 3-3, DBS 2-3 and DBS 3-2 patterns, 
respectively, all three at 50 Hz. 
 
 
 
0,2 ms 
1 s 
0,2 ms 
20 ms 
750 ms 
Figure 1.3 – TOF pattern. 
Figure 1.4 – DBS 3-3 pattern. 
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d) Tetanic stimulation 
 
The Tetanic stimulation is accomplished by applying an intense stimulus for 5 s at 50-120 
Hz to promote the release of ACh at the NMJ. The result is a detectable fade in muscle 
contraction whose extent is related to the NMB extent [17]. In the presence of non-depolarizing 
NMBDs at the NMJ, the response to tetanus fades [9]. The higher the frequency of tetanic 
stimulation, the more evident is the fade [3]. High frequency stimulation of the motor nerve 
produces a great discharge of ACh in the synaptic cleft. This leads to a decrease in ACh release 
until the equilibrium between mobilization and synthesis is reached. To produce a full muscular 
response in a normal muscular contraction, the nerve is stimulated with a high frequency 
stimulus for a higher release of ACh above the necessary (margin of safety). However, in the 
presence of non-depolarizing NMB, the number of available nAChR is reduced. This reduces the 
margin of safety of neuromuscular transmission, decreasing the force of muscle contraction – 
fade [21]. At the end of tetanus, another reaction occurs – post-tetanic facilitation – 
characterized by a transient excessive release of ACh at the NMJ. The effect of this 
phenomenon depends on the duration and intensity of the stimulus. It can last 3-5 minutes 
after a 5 s stimulation at 50 Hz. Therefore, to avoid an overestimation of the extent of 
neuromuscular recovery, the monitoring is not recommended during this period.  
Tetanic stimulation is painful, and the higher the stimulation frequency is, the more the 
patient feels pain. For that reason, this stimulation mode may only be employed on 
anesthetized patients. For current clinical applications, tetanic stimulation is not as relevant 
0,2 ms 
20 ms 
750 ms 
0,2 ms 
20 ms 
750 ms 
Figure 1.5 – DBS 2-3 pattern. 
Figure 1.6 – DBS 3-2 pattern. 
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as an individual stimulation pattern, being only used as a component in the post-tetanic count 
[3].  
Figure 1.7 demonstrates the tetanus pattern at 50 Hz.  
 
 
e) Post-tetanic twitch count 
 
The Post-tetanic twitch count (PTC) consists of a sequence of events, beginning with a 
tetanic stimulus, followed 3 s later by 10 or 20 single supramaximal stimuli at a frequency of 1 
Hz. As previously mentioned, the optimal interval between two PTC stimulations is 3 minutes. 
In this stimulation mode, the assessment of response do not include the tetanus because it is 
only used to promote the post-tetanic potentiation phenomenon [3].  
Figure 1.8 represents the PTC pattern in which the tetanus stimulus is at 50 Hz, followed 3 
s later by 10 single twitches at 1 Hz. 
 
PTC is important to monitor deep NMB after administration of non-depolarizing NMBAs. In 
deep NMB, TOF or Single Twitch stimulation evokes no response, and so the extent of block 
cannot be evaluated. However, post-tetanic potentiation may induce muscle contraction in 
response to further stimuli, informing about the degree of NMB. The extent of NMB is inversely 
proportional to the number of detected responses [22]. 
 
Figure 1.7 – Tetanus pattern. 
0,2 ms 
20 ms 
5 s 
0,2 ms 
1 s 
0,2 ms 
20 ms 
5 s 3 s 
Figure 1.8 – PTC pattern. 
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Depolarizing NMBAs react differently to the peripheral nervous system modes of 
stimulation. They produce equal bit reduced twitches in response to single twitch and TOF 
stimulation (the T4:T1 ratio is 1), reduced but sustained contraction with tetanic stimulation, 
and do not demonstrate neither tetanic fade or post-tetanic potentiation [17].  
 
1.4.3 - Deep Blockade 
 
The proper depth of intraoperative NMB depends on the type and phase of the surgical 
procedure, and also on the anaesthetic method. The block should not be deeper than the 
necessary and for most of the surgical procedures a TOF count of 1-2 is sufficient. However, 
when a deep NMB is required, no evoked response should be detected with TOF stimulation 
[23].  
It is verified that after an intubation dose of a non-depolarizing NMBD, it takes 20-40 min 
until the first TOF response is once more discernible. During this period, TOF mode do not give 
additional information about the NMB extent. Therefore, neuromuscular monitoring must 
provide information regarding the depth of NMB for the anaesthetist to reinject NMBDs in a 
controlled way, preventing an overdose and cumulative effects [3]. So, if the NMB is too deep 
for TOF monitoring, i.e., no responses in after TOF stimulation, then PTC should be used to 
provide a better monitoring. A PTC of 1-2 reveals a very deep blockade, virtually ensuring 
muscles immobility. After the assessment of PTC stimulation results, it is possible to ensure 
total paralysis of the diaphragm, while total elimination of the response to TOF stimulation 
does not exclude the possibility of movement of diaphragm, such as hiccupping and coughing 
[24]. This is very important in certain procedures, namely neurosurgical, open eye surgical 
procedures and laparoscopic surgeries [23][25]. 
 
1.4.4 - Sites of Stimulation 
 
The site of neuromuscular stimulation depends on many factors, being the most important 
one the accessibility to a superficial nerve. In clinical anaesthesia, the ulnar nerve at the wrist 
is the most common site for nerve stimulation, and the response at the adductor pollicis muscle 
is assessed by the thumb adduction [23]. During many surgical procedures, the patient’s arm 
may not be accessible due to the procedure and to the positioning of the arms [24]. When this 
muscle is not available bilaterally, the next best site for the evaluation is the great toe with 
stimulation of the posterior tibial nerve [26].  
Muscle groups differ in their sensitivity to muscle relaxants. Therefore, the results obtained 
in monitoring one muscle group may not accurately reflect the state of relaxation at another 
muscle group. Possible causes may be differences in ACh receptor density, ACh release, ACh 
activity, fibre composition, innervation ratio, blood flow, and muscle temperature [24]. For 
example, the diaphragm is the most resistant of all muscles to both depolarizing and non-
depolarizing NMBDs. In general, the diaphragm requires 1.4-2 times more muscle relaxant than 
the adductor pollicis muscle for an identical degree of blockade [27]. Also of clinical 
significance is the fact that onset time is normally shorter for the diaphragm than for the 
adductor pollicis muscle, recovering from paralysis more quickly than the peripheral muscles 
[28]. The other respiratory muscles are less resistant than the diaphragm, as are the larynx and 
the corrugator supercilii muscle [29]. Most sensitive are the abdominal muscles, the orbicularis 
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oculi muscle, the peripheral muscles of the limbs, and the geniohoyd, masseter, and upper 
airways muscles [24].  
During recovery, when the adductor pollicis has recovered sufficiently, it can be assumed 
that no residual NMB exists in the diaphragm or in other resistant muscles [24].  
Optimal nerve stimulation occurs when the negative electrode is placed directly over the 
nerve. The positive electrode is placed proximal to the negative electrode to avoid depolarizing 
a different nerve. For ulnar nerve stimulation, electrodes are best applied on the volar side of 
wrist [24]. Direct muscle stimulation must be avoided, as it may result in an enhanced response 
and underestimation of the degree of overall blockade [30]. 
 
1.4.5 - Nerve Stimulator Requirements 
 
A nerve stimulator delivers stimuli to electrodes. Although many nerve stimulators are 
commercially available, not all meet the optimal standards for clinical use. Ideally, a nerve 
stimulator should admit the following properties:   
1. The waveform signal must be monophasic and rectangular [14].  
2. It should provide different modes of stimulation (Single twitch, TOF, Tetanic 
stimulation, PTC and DBS), satisfying the physiological requirements associated to each 
mode. Nonetheless, the device must give the clinician the opportunity to change 
certain parameters such as frequency, current and duration of stimuli. 
3. It must deliver a constant current because current is the determinant of nerve 
stimulation. In case the unit cannot deliver the specified current to the nerve, an alarm 
should be displayed [31].  
4. For safety reasons, the nerve stimulator should not generate currents higher 
than 80 mA [24]. 
5. It must be battery operated, and include a battery check. 
6. It should have polarity indicators for electrodes. 
7. It must allow a quantitative measurement of the evoked responses. 
8. It must present a user-friendly interface. 
Many commercially available stimulators deliver just 25-50 mA and provide a constant 
current only when skin resistance ranges from 0 to 2.5 kΩ. However, during cooling, skin 
resistance may increase to approximately 5 kΩ, which may cause the current delivered to the 
nerve to fall below the supramaximal level, causing a decrease in the response to stimulation. 
This may lead to a misjudging of the degree of NMB [24].  
A quantitative measurement of the evoked responses was mentioned because it has been 
proven that a quantitative monitoring should be used routinely for patients receiving 
nondepolarizing NMBDs [32]. 
1.4 - Assessment of Stimulatory Response 
 
Many anaesthetists continue to determine whether the patient has undergone adequate 
neuromuscular recovery at the end of surgery relying on clinical tests such as head and leg lift, 
and hand grip [12][32]. Such clinical evaluation is not always accurate in predicting 
neuromuscular recovery because provide insensitive indicators of residual skeletal muscle 
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weakness, being only applicable to awake patients. For example, it has been shown that 12% 
of patients who had a good response to clinical tests were still at risk for residual block [12][32]. 
Along with these qualitative assessment methods, there are conventional nerve stimulators, 
also referred as subjective or qualitative which rely on subjective visual or tactile assessment 
of the relative strength of the twitches after electrical stimulation of ulnar nerve using TOF. A 
major limitation of a qualitative stimulation monitor is that it cannot confirm that reversal is 
successful, i.e., the absence of residual paralysis, which is currently defined as a TOF ratio 
minor than 0.9 at adductor pollicis muscle [33]. This qualitative tests do not provide an 
objective, quantitative assessment of the amplitudes of the twitch heights. Therefore, a nerve 
stimulator capable of reliably and quantitatively measure TOF ratios throughout the entire 
range would be of great clinical interest [23]. Quantitative nerve stimulators provide to the 
anaesthetist an objective measurement of the stimulatory response, allowing an accurate 
determination of the degree of neuromuscular recovery. The major methods rely on 
measurement of: evoked mechanical response of the muscle (mechanomyography), evoked 
electrical response of the muscle (electromyography), acceleration of the muscle response 
(acceleromyography), and evoked electrical response in a piezoelectric film sensor attached to 
the muscle (kinemyography) [24].  
 
1.5.1 - Mechanomyography 
 
Mechanomyography measures the isometric contraction of adductor pollicis muscle 
response after supramaximal stimulation of the ulnar nerve. This is the only method that 
directly measures the muscle force. With the hand supinated, the thumb is abducted at a 
preload of 200-300g attached to the thumb and restrained in this position. A force transducer 
is used for this purpose and must be aligned with the direction of movement of the thumb, for 
accurate measurements. Moreover, the hand must be immobilized since a slight change in the 
hand’s position can significantly alter the degree of abduction [3][24]. 
For clinical use, mechanomyography remains the “gold standard”, but these devices are 
bulky. It has been used as a research tool and restricted to the adductor pollicis muscle [29]. 
 
1.5.2 - Electromyography 
 
Electromyography records the electrical activity of the stimulated muscle, which has a 
behavior similar to the change in muscle strength. This method records the compound action 
potentials produced by stimulation of individual muscles and/or muscle groups in the supply 
area of a nerve [3]. Most commonly, three electrodes are positioned to give the most consistent 
electromyography signals: one electrode is placed over the mid-portion of the muscle and the 
other is placed over the muscle tendon or finger; the placement of the third electrode (neutral) 
is variable. Clinically, electromyography is most often recorded from the hypothenar region of 
the hand, in response to supramaximal ulnar nerve stimulation at the wrist [34].  
After stimulation of the associated motor nerve, the amplitude of the evoked electrical 
response can be recorded, and represents either the sum of the individual compound muscle 
action potentials or the area under the electromyography curve [35]. Data collected by 
electromyography shows a good correlation with those obtained by mechanomyography [36]. 
Comparing both methods, electromyography is less bulky and easy to set up, can be recorded 
from a wider group of muscles, gives information about spontaneous muscle activity such as 
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breathing and does not require immobilization of the arm. Nonetheless, it is more expensive 
and the quality of electromyography signal is undesirably affected by electrical interference, 
incorrect electrodes placement, direct muscle stimulation and hypothermia [24][34]. 
 
 
 
1.5.3 - Acceleromyography 
 
Acceleromyography measures the isotonic acceleration of the stimulated muscle. It is based 
on Newton’s law, which states that force equals mass times acceleration. As mass is held 
constant, the muscle contraction in response to nerve stimulation is directly proportional to 
acceleration. Acceleromyography can be performed on muscles whose movement can be easily 
measured namely the adductor pollicis (thumb), the flexor halluces brevis (foot), orbicularis 
occuli and corrugator supercilii (face) muscles. Typically, the ulnar nerve is stimulated and the 
acceleration is measured with a piezoelectric transducer fixed to the thumb [3]. That is, 
whenever the thumb moves, a voltage is generated which is proportional to the angular 
acceleration.  
The accuracy of measurement reduces with interferences of free thumb movement, so the 
hand must be restrained in a supinated position [3]. However, accelerometers are less bulky 
and easier to use than force transducers. Also, as isotonic contraction is measured, acceleration 
transducer do not require preload and can be used in more sites than those used in 
mechanomyography. In addition, there is a good correlation between acceleromyography data 
and those obtained in mechanomyography [37]. 
 
1.5.4 - Kinemyography 
 
Kinemyography is based upon the detection of bending and deformation of a piezoelectric 
sensor wafer strip by movement of the thumb, which is caused by contraction of the adductor 
pollicis muscle [38]. This method measures the electrical current generated after deformation 
of the mechanosensor. It consists of a moulded plastic device which is placed into the groove 
of the thumb and forefinger by use of adhesive tape. Angular velocity of the thumb, after ulnar 
nerve electrical stimulation, depends on the force of muscle contractions, which varies 
accordingly to the level of NMB.  
The hand can be placed in any position as long as it does not interfere with the movement 
of the thumb and therefore, deform the mechanosensor. A disadvantage of this method it that 
the device only measures the NMB at the adductor pollicis muscle [3]. 
1.5 - Stimulator devices 
 
The two main methods used for NMB degree assessment are acceleromyography and 
kinemyography. Both methods are used in Centro Hospitalar do Porto operating rooms, being 
applied on a daily basis.  
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TOF-Watch and Datex-Ohmeda M-NMT are the most used neuromuscular transmitters in 
operating rooms [39].  Yet, surveys have shown that TOF-Watch is the most frequently used 
nerve stimulator for clinical monitoring of NMB. 
 
1.6.1 – TOF-Watch 
 
The TOF-Watch module (Figure 1.9) provides quantitative and automatic measurement of 
muscle response to a stimulus by the acceleromyography method. The TOF-Watch monitor was 
the last NMB monitor in the market that was validated for clinical research. The stimulator in 
the TOF-Watch is of constant current type; pulse current can be set in a range of 0-60 mA, 
being the default value of 50 mA. Calibration is a crucial topic as the size of responses varies 
from patient to patient. So, the control twitch height (i.e. twitch height when the patient is 
not relaxed) is set to 100% after a stimulus at 1Hz or 0.1 Hz. Available stimulation modes are 
TOF, PTC stimulation, DBS, Single twitch at 1Hz or 0.1 Hz, DBS and Tetanic stimulation at 50 
Hz or 100 Hz. The unit displays TOF ratio %, count of number of responses after TOF, twitch 
height % of the last response after 1 Hz or 0.1 Hz stimulation, and PTC of detected responses. 
With DBS and Tetanic stimulation, only tactile evaluation can be performed to evaluate the 
patient’s relaxation; the display do not show response [40].   
 
 
Figure 1.9 - TOF-Watch monitor. (1) Stimulating electrodes applied over ulnar nerve; (2) accelerometer 
taped to thumb; (3) display screen [39]. 
 
1.6.2 – Datex-Ohmeda M-NMT 
 
The Datex-Ohmeda M-NMT module (Figure 1.10) provides quantitative and automatic 
measurement of muscle response to a stimulus by the kinemyography method. The 
kinemyographic mechanosensor is available for adults and for paediatric use. This sensor can 
be detached from the device and substituted by an electrosensor which provides an 
  
15 
 
electromyographic evaluation of muscle response. The latter sensor is essential for the module 
to obtain PTC of the first electromyographic responses. This module provides a constant current 
supramaximal stimulus. The unit displays TOF ratio %, T1% (i.e. T1 in relation to baseline), and 
the number of responses after TOF and PTC. Other stimulation patterns can also be used, such 
as DBS and single-twitch [41]. The unit displays TOF ratio numerically on the monitor, and a 
bar graph of all four responses so that this ratio may be verified visually [42]. It was proven 
that the recovery from NMB is overestimated with kinemyography method when compared with 
electromyography method [43]. The lack of technical details regarding Datex-Ohmeda M-NMT 
module impairs the analysis of module electrical settings.   
 
 
 
 
 
 
 
 
 
 
 
Figure 1.10 - Datex–Ohmeda M-NMT neuromuscular transmission module with kinemyographic 
mechanosensor. (1) Stimulating electrodes applied over ulnar nerve; (2) piezoelectric mechanosensor 
[39]. 
 
Since nerve stimulation can be painful for a conscious patient, the patient should be 
anaesthetized before operating the stimulator [40].  
In both devices, TOF is used as a standard stimulation mode. Moreover, the display screen 
indicates TOF ratio when the four responses are detected; in case the fourth response is not 
sensed, TOF ratio cannot be calculated and is only indicated the number of responses [39]. 
Among the available methods for objective neuromuscular monitoring acceleromyography 
is the most widely distributed method [44]. It is an easier monitoring method to apply 
comparing with the other two quantitative neuromuscular monitoring methods, i.e., 
kinemyography and electromyography [3].  
In a study focused on comparing the TOF-ratio measured with acceleromyography (TOF-
Watch) and electromyography (Datex-Ohmeda M-NMT), was verified that the first method was 
able to detect residual neuromuscular blockade with higher precision [45]. 
 
Recent studies carried out by Mafalda Couto (Doctoral Student in Leaders for Technological 
Industries – EDA, FEUP) have shown interesting data regarding limitations of current 
neuromuscular transmission monitors. Such drawbacks impair a correct assessment of NMB 
extent which has been proven to be of great value for anaesthetists; also, motivated the 
development of the proposed system – the goal of this project. 
Preliminary clinical testing took place in Centro Hospitalar do Porto. The non-depolarizing 
NMD Rocuronium and the reversal drug Sugammadex were administered to patients. TOF-Watch 
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was used as monitor. Collected data is still under analysis but by far, some consistent facts 
were verified: 
 For the same patient, PTC stimulation at 50Hz induces different evoked 
responses that the ones found at 100Hz. It proves that patient’s evoked responses vary 
according to stimuli frequency. Therefore, patients may not be stimulated at the 
frequency that evokes the best representative responses of actual NMB extent. 
 The used monitor do not interpret the output. After administration of a non-
depolarizing NMD, the magnitude of responses decrease from T1 to T4, sequentially. 
However, this fade, which represents muscle fatigue, is not always observed (e.g., 
T2>T1), leading to an erroneous calculation of TOF ratio and representation of muscle 
responses, which was not communicated to the anaesthetist.  
 
The proposed system is a neuromuscular stimulator that aims to change the paradigm of 
NMB assessment by providing a personalized stimulation attending to initial responses of each 
patient.  
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Chapter 2: Proposed device 
A neuromuscular stimulator is a device used by anaesthetists for NMB monitoring. Circuits 
of neuromuscular stimulators were found, though those stimulators were for transcutaneous 
electrical nerve stimulation (TENS). TENS is used as a nonpharmacologic and noninvasive 
treatment for pain [46]. Therefore, the output voltage and current are much lower than the 
neuromuscular stimulators used in operating rooms. Most of the found circuits were analog, 
which is a deprecated feature for a medical device. In this sense, the presented device was 
designed from scratch and according to the specifications of an ideal stimulator prototype (see 
Table 2.1).  
 
Table 2.1 – Device specifications. 
 
 
 
 
 
 
 
 
The output voltage may range between 5 and 300 V to be able to provide 5-60 mA over a 
skin resistance that may range between 1-5 kΩ. 
This device must be portable and able to connect to a tablet or computer through a USB 
cable. Wireless communication allows the transference of information over a distance without 
the use of wires, and so wireless technologies in the operating room (OR) present a lot of 
advantages, namely:  
 May minimize the electrical connections necessary for safe patient care, and enhance 
wireless transmission of critical medical alarms and real-time control of medical 
devices [47]; 
 Reduces OR clutter by eliminating traditional cables; 
 Decreases risk of contamination (cables are often exposed to contamination); 
 Decrease repair costs (monitors are frequently damaged due to misuse of cable by OR 
staff; cables are damaged by wear and tear) [48]; 
 Increase the free space in OR for a better mobility of the surgical team. 
Parameter Min Max Unit 
Output voltage 5 300 V 
Output current 5 60 mA 
Stimuli frequency 0.1 120 Hz 
Power supply 
(battery) 
9 V 
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However, many studies have reported findings of electromagnetic interference (EMI) in 
several medical devices (e.g. defibrillators, ventilators, brain stimulators, pumps and 
ophthalmic equipment) caused by different types of wireless devices operating on a variety of 
transmission technologies including Bluetooth [49][50]. The recorded levels of EMI did not pose 
significant risk to life supporting medical devices. Though, have been observed EMIs described 
as hazardous in 12-lead ECG machines, anaesthesia monitors and echocardiogram/ultrasound 
machines [51].   
Current instruments for monitoring the neuromuscular transmission during surgery are not 
wireless, and in this sense the presented device will have the same characteristic, although 
being now relatively easy to include this feature.  
Standard Arduino boards, e.g. Uno, do not offer any wireless connection, such as Bluetooth 
or Wi-Fi. Yet, there are modules that enable the microcontroller board to communicate 
wirelessly. 
The developed system main concept tackles a circuit in which is guaranteed a correctly 
controlled current signal - since over current can severely damage body tissues – whose 
waveform is according to the intended stimulation pattern chosen in a user interface. The 
presented circuit is composed by a 9V alkaline battery, a voltage regulator, a current source, 
a digital potentiometer, and a digital switch. Figure 2.1 is a representation of the developed 
system. 
 
 
The current source integrates the circuit to yield a constant output current, whose value 
is controlled by the digital potentiometer. The signal from the current source is the input for 
the digital switch. The aim of the digital switch on the circuit is to control the output signal, 
being programmed to open (no signal) and to close (conducting) accordingly to the 
Figure 2.1 - Diagram of the developed system. 
Electrical  signal 
Control 
Data transmission 
Legend: 
Current source 
Digital 
potentiometer 
Microcontroller 
Digital switch 
PC 
Electrodes 
Device 
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Distal electrode 
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characteristics for each stimulation pattern. A voltage regulator provides the proper input 
voltage for the digital potentiometer since its maximum VDD is 5.5 V; it also powers the current 
source and the digital switch. The microcontroller controls both digital potentiometer (via I2C 
protocol) and digital switch, and communicate with an interface developed in LabVIEW. The 
user interface is a simple way to the anaesthetist manipulate the device to achieve the 
intended output. Although the output signal should be transmitted to the patient by the use of 
electrodes both located in the ulnar nerve, no stimulation was applied to the any human at 
this stage of development.  
 
Certain components present electronic limitations that impair, a priori, the correct 
functioning of the device. The ideal current source should output a voltage such that the 
stimulator could provide the current defined by the anaesthetist regardless the skin resistance, 
with an input voltage of 9 V from the battery. In this sense, the signal output voltage is a 
parameter that will not be taken into account in the results since it is known that the desired 
values will not be achieved due to voltage limitations of the used current source. 
Moreover, the maximum electronic current allowed by the digital switch is 30 mA, when 
the desired range of output current is 0-60 mA. 
 
A theoretical explanation about each component is presented below, as well as a few 
practical considerations and proofs about their functioning.  
 
2.1 – Electronic circuit 
 
2.1.1 - Voltage regulator 
 
A voltage regulator generates a fixed output voltage that remains steady regardless of 
changes to its input voltage or load conditions. There are mainly two types of voltage 
regulators: linear and switching [52]. The chosen voltage regulator is the L7805 fixed linear IC 
voltage regulator that generates fixed voltage of 5V when the load is less than 1.5 A. This 
voltage regulator is accompanied by a 0.33 µF electrolytic input and a 0.1 µF ceramic output 
decoupling capacitors. They provide a low-impedance path at the input and output of the 
L7805, suppress high frequency noise from the source and/or from the load (e.g. peak currents 
caused by rapid changes in current), reduce voltage transients on the input of the L7805, and 
reach electromagnetic compatibility (EMC). As the power source is a battery, the input 
capacitor is not a must, yet recommended. Although no output capacitor is needed for stability, 
the output capacitor is used to improve transient response [53]. 
According to datasheet, for values of output capacitance ≤ 10 µF no protection diode is 
required. A protection diode is used to protect the circuit from reverse voltage and current by 
only allowing current to flow in the forward direction and blocking current in the reverse 
direction. It is normally placed reverse biased in parallel with the component so if current flows 
through the circuit in reverse, the current flows through the diode, bypassing the L7805 [54].  
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2.1.2 - Current source 
 
A current source is an active circuit element capable of supplying a constant current 
regardless of the voltage across its terminals. Ideally, a constant current source provides a 
constant current independently of the load connected to it [55]. The LT3092 is the chosen 
programmable 2-terminal current source. It needs only two external resistors; no external 
bypass capacitors are needed for stability [56] (see Figure 2.2). It was preferred once the 
output current can be set between 0.5 mA and 200mA, an adequate range of current for this 
project. Since this current is to be applied to the human body, the device must output the 
shortest range of current, yet complying the required interval of values (5-60 mA).  
 
 
 
 
 
 
 
 
 
 
Figure 2.2 - Functional diagram of the LT3092 as a current source [56]. 
 The LT3092 requires only two resistors to set a constant current. It uses a precision 10 
µA reference current source and a voltage-follower circuit. This current connects to the 
noninverting input of an operational amplifier which provides a low impedance buffered output 
of the voltage on the noninverting input (see Figure 2.2). The SET node is also the input to the 
voltage follower, which is set up so that the voltage on the OUT pin is the same as on the SET 
pin [57]. A small voltage in the range of 100 mV to 1 V is generated by the reference current 
from the SET pin, with the RSET resistor. Such voltage is applied across ROUT. The equation (2.1) 
determines the output current. 
 
𝐼𝑂𝑈𝑇 =
𝑉𝑆𝐸𝑇
𝑅𝑂𝑈𝑇
=
10 𝜇𝐴 ∙ 𝑅𝑆𝐸𝑇
𝑅𝑂𝑈𝑇
  (𝑚𝐴)                                                           (2.1) 
 
Where: 
IOUT is the OUT pin current; 
VSET is the SET pin voltage; 
ROUT is the value of the resistance connected to OUT pin; 
RSET is the value of the resistance connected to SET pin. 
 
According to equation (2.1), the output current is set by the ratio of both RSET and ROUT. So, 
it is crucial to calculate the resistors. The RSET must be such that generates a voltage across 
RSET between 100 mV to 1 V as mentioned above. Therefore, RSET may assume values from 10 
kΩ up to 100 kΩ. Though, it is known that at a particular voltage of 200 mV at the SET pin, any 
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errors generated in the internal constant current source and any errors in the offset voltage in 
the amplifier circuit are cancelled out. So, the desired RSET is 20 kΩ.  
As it is necessary to obtain a variable current, RSET must be programmable to vary, such as 
a digital potentiometer does. It should be chosen a 20 kΩ digital potentiometer, but attending 
to the available material, in this project it is used a 10 kΩ.  
So, once defined the output current and the value of the potentiometer, ROUT is quickly 
calculated. For the project, it was chosen a Rout equal to 1Ω so that a range of 0.5 – 100 mA 
could be achieved once the voltage on the OUT pin is 100mV due to RSET being equal to 10 kΩ. 
 
2.1.3 - Digital potentiometer 
 
The AD5241 is a 256-position digitally controlled variable resistor device with a 10 kΩ 
nominal resistance. A digital potentiometer is a variable resistor which is controlled by digital 
signals.  
A potentiometer is an adjustable variable resistor with three terminals: two terminals are 
connected to a resistive element and the third terminal is connected to an adjustable wiper. 
 According to Figure 2.3, pins 1, 2 and 3 represent pins A1, wiper and B1 in AD5241. By 
connecting only two pins – the wiper and A1 or B1 – to the current source, the AD5142 turns a 
rheostat, which is its purpose on the circuit.  
Figure 2.3 - Potentiometer's behaviour as a rheostat [58]. 
 
A rheostat is a two-terminal variable resistor that by changing the value of the wiper, the 
amount of resistance linearly increases or decreases. It is commonly used to control current by 
changing the value of its resistance.  
As can be seen from Figure 2.3, the effective resistance is between pin B1 and the wiper. 
As A1 is not connected, the resistance between A1 and the wiper is open-circuited and has no 
effect on the load current. If both pins are connected, than that part of the resistive track is 
short-circuited, and so has no effect on load current.  
After a brief explanation about how a potentiometer works, becomes easier to interpret 
the scheme of a digital potentiometer (see Figure 2.4). The digital potentiometer configuration 
contains CMOS (complementary metal-oxide-semiconductor) switches placed between 
terminals A and B. The switch selected by the digital input connects the wiper to the 
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corresponding value on the resistor string – the end-to-end potentiometer resistance. The 
number of resistors in the sting determines the resolution of the potentiometer [59]. 
 
Figure 2.4 - Functional diagram of the AD5241 [60].  
 
The nominal resistance (RAB) of the AD5241 has 256 (8-bit data) contact points accessed by 
the wiper terminal plus the B terminal contact. There is a minimum of 60 Ω resistance between 
terminal W and B due to a 60 Ω wiper contact resistance contributed by the on resistance of 
the internal switch. The increase of the least-significant bit (LSB) data value moves the wiper 
up the “resistor ladder” until the last step is reached [60]. The equation (2.2) determines the 
digitally programmed resistance between W and B. 
𝑅𝑊𝐵(𝐷) =  
𝐷
256
× 𝑅𝐴𝐵 + 𝑅𝑊   (𝛺)                                                     (2.2) 
where:  
D is the decimal equivalent of the binary code between 0 and 255 which is loaded in the 8-
bit register; 
RAB is the nominal end-to-end resistance; 
RW is the wiper resistance. 
 
2.1.4 - Digital switch 
 
      The chosen digital switch is the TS12A44513, a device that contains four bidirectional 
single-pole single-throw (SPST) single-supply CMOS analog switches. A SPST switch can control 
only one circuit (single pole) and the switch’s pole is connected to only one position (single 
throw). Two of the switches are normally closed (NC) switches and two normally open (NO) 
[61]. As the switches are bidirectional, NO, NC and COM pins can be used as inputs or outputs. 
Figure 2.5 shows the functional diagram of the device. 
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Figure 2.5 - Functional diagram of the TS12A44513 [61]. 
It is recommended that the digital control pin (IN) be pulled up to VCC or down to GND to 
avoid undesired switch positions (see Figure 2.6). According to Figure 2.6, the pre-set values 
of the resistor and capacitor connected to COM pin result in a switching time of about 10 ns. 
Figure 2.6 - Circuit of the TS12A44513 [61]. 
 
2.2 - Practical considerations 
 
2.2.1 - Test equipments 
 
The test equipments used during the development of the project were: the Velleman 
LABPS23023 Dual DC Lab Power Supply, the Kaise MY-64 multimeter, the Tenma 72-1020 bench 
digital multimeter, and the Rigol DS1054Z digital oscilloscope 50 Mhz DSO 4 Channels.  
 
2.2.2 - Voltage regulator 
 
The voltage regulator circuit converts the 9V from the power supply (alkaline battery) to 
5V. Figure 2.7 shows the schematic drawn in Eagle. 
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2.2.3 - Digital potentiometer 
 
To test the digital potentiometer wiring, a test setup was performed. In this matter, it was 
measured the resistance with a multimeter, for different values set for the wiper. Using the 
equation (2.2), it is possible to compare the experimental and the expected resistance. Table 
2.2 shows the obtained results. 
  
Table 2.2 - Expected and measured resistance values. 
Expected resistance value (Ω) Measured resistance values (Ω) 
60 42 
99 75 
451 427 
2013 1990 
3966 3940 
5919 5900 
7873 7860 
9826 9800 
10021 10002 
Mean error (%) 6,81 
 
This test was performed to ensure the correct input voltage to the current source 
component. Therefore, after demonstrating the AD5241 was operational, it could be connected 
to the current source. 
 
2.2.4 - Current source 
 
As previously mentioned, the current source regulates the output current based on two 
resistors. In this project, those resistors are a 1 Ω resistor and a 10 kΩ digital potentiometer. 
Attending to equation 2.1, varying the resistance provided by the digital potentiometer, output 
current may range from 0 up 100 mA, ideally. Figure 2.8 shows how the output current changes 
with the digital potentiometer when using an ROUT equal to 1 Ω. 
Figure 2.7 – Eagle schematic of the voltage regulator circuit. 
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The tendency curve presented on Figure 2.8 was used to predict the wiper value when 
the user selects a specific stimulation current. Its equation is showed below: 
 
𝑂𝑢𝑡𝑝𝑢𝑡 𝑐𝑢𝑟𝑟𝑒𝑛𝑡 = 0,3861 ∙ 𝑤𝑖𝑝𝑒𝑟 𝑣𝑎𝑙𝑢𝑒 + 0,482   (𝑚𝐴)                                     (2.3) 
 
where: 
Output current is the current value selected by the user on the interface; 
Wiper value varies between 0 and 255.   
 
The stimulation current is correctly programmed since a small mean error of 1,67% between 
the expected and experimental values was calculated. 
To predict the current behaviour when the signal is applied on the human skin, was placed 
a load in the output of the current source. The load is a resistor with a value in the range of 
the skin resistance. The tested resistance values were 1,2 kΩ and 3,3 kΩ. As the voltage is 
limited, when a load is added, the maximum output current decreases as the load resistance 
increases, according to Ohm’s law (see Figure 2.9). 
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Figure 2.8 - Output current according to the wiper value. 
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Figure 2.9 – Output current using load resistances of 1,2 kΩ and 3,3 kΩ. 
26 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This page was intentionally left blank 
 
 
  
 
  27 
  
Chapter 3: Software development 
3.1 – LabVIEW interface 
 
The LabVIEW interface was created to ease the user experience, allowing the user to 
programme the device in a simple way. Parameters such as current and waveform 
characteristics of stimulation patterns are defined by the user through the interface (Figure 
3.1). 
Figure 3.2   provides a general concept of interface execution.  A more detailed explanation 
is provided next. 
The interface is divided in three sections: 
 Stimulus patterns: presents all stimulation patterns clinically used in neuromuscular 
monitoring. 
 Stimulus settings: contains settings related to each stimulus pattern waveform; pulse 
duration and current are parameters common to all patterns. 
 Control panel:   comprises a set of buttons that control the execution of the program. 
As can be observed in Figure 3.1, when the executable is run, only the stimulation buttons 
are enabled. When it is pressed a stimulation button, e.g. Single twitch (Figure 3.3), its settings 
become enabled (Single twitch frequency, pulse duration and current) and user can change, or 
not, their values by pressing the corresponding Ring Menu and choosing the intended option – 
0,1 Hz as observed on Figure 3.4. The buttons “Clear settings” and “Confirm settings” are also 
enabled. The first one, when pressed, returns all settings to their default value; the second 
one, when pressed, enables the “Start stimulation” button (Figure 3.5). So, at that point, user 
can change all performed alterations or submit them by pressing “Confirm settings”. If pressed, 
user can start the stimulation when desired by pressing “Start stimulation”. As soon as the 
stimulation begins, all buttons in the Stimulus settings panel become disabled and grayed out, 
as well as the “Start stimulation” and “Clear settings” buttons, and a LED turns on in the 
stimulus button. Meanwhile, “Stop stimulation” and “Record stimulus” are enabled (Figure 
3.6). The first one allows the user to stop the program, and the other permits the recording of 
the selected pattern data in a text file, whose path can be defined by the user. It opens an 
existing file or creates a new file if one does not exist; this feature can be important for 
research purposes. For Single twitch and TOF stimulation patterns, it is possible to interrupt 
the stimulation at any point by just pressing other stimulation button (Figure 3.7). Those 
stimulus are the only cyclic and at low frequency. For the other patterns, such operation is not 
allowed since are performed only one time, so the stimulus must be completely delivered. 
Thus, in case a Tetanus stimulus is chosen and user presses the “Start stimulation” button, all 
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the stimulation button are immediately disabled until the end of the stimulus (Figure 3.8). This 
system of enabled/disabled buttons is important to guide the user in the manipulation of the 
interface, decreasing operation errors.
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Figure 3.1 - User interface. 
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Choose a stimulus pattern 
Select the intended value for each parameter 
Press stimulus 
button? 
Settings related to the selected pattern are enable; 
others are disabled and grayed out 
Desire to modify 
stimulus waveform 
parameters? 
Start 
stimulation? 
Press start stimulation button 
Stimulation buttons are disabled and grayed out 
until end of stimulus 
Change stimulation 
pattern? 
Stop 
stimulation? 
Press stop stimulation button 
Yes 
No 
Yes 
No 
Yes 
Yes 
No 
Yes 
End 
Start 
No 
Figure 3.2 – General diagram of interface functioning. 
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Figure 3.3 – User interface. The chosen stimulus pattern is Single twitch. 
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Figure 3.4 – User interface. After selecting the stimulation pattern, the corresponding parameters can be adapted. 
  
   33 
  
 
Figure 3.5 – User interface. When pressed the “Confirm settings” button, the “Start stimulation” button becomes enabled. 
34 
 
 
Figure 3.6 – User interface. When the stimulation starts, the LED placed in the selected stimulation button is turned on. 
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Figure 3.7 – User interface. Since the previous selected pattern was Single twitch, other pattern can interrupt the transmission of the stimulus, e.g. Tetanus. 
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Figure 3.8 – User interface. While a Tetanus stimulus is transmitted, the remaining stimulation pattern buttons are disabled. The same happens for PTC, DBS 3:3, 
DBS 2:3 and DBS 3:2. 
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After running the program, it is initialized the serial port allowing the communication with 
Arduino. Such communication is necessary since the parameters chosen by the user in the 
interface define the waveform of the stimulus and the output current, and it is the 
microcontroller which controls the digital switch and the digital potentiometer in order to be 
achieved an output signal that accomplishes the user requirements. For that, LabVIEW sends a 
message string to Arduino, through serial communication, comprising data regarding the 
nominated stimulation pattern and all settings, independently of the selected pattern. To send 
a short and constant message length, for each parameter in the message, it is sent just a 
number that represents each option. Figure 3.9 shows how the structure of the sent message.  
 
In the example of Figure 3.9, Single twitch was the selected pattern. As it was defined as 
number 1 among the other patterns, the first passage parameter adopts the value 1. Moreover, 
choosing a stimulation frequency of 1 Hz, the second parameter assumes the value 3, and so 
Stimulation pattern 1 
Single twitch frequency 3 
TOF frequency  
Tetanus frequency  
PTC first burst frequency  
PTC second burst frequency  
TOF-TOF interval  
PTC twitches  
Pulse duration  
Current  
 \r\n 
Figure 3.9 – Structure of the message sent from LabVIEW to Arduino. 
 
Labview message 
structure 
Termination character 
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on. The parameters that are not changed and the ones not associated with the chosen pattern 
are set with their default value. An end of the line termination character (“\r\n”) is added in 
the end for the Arduino to recognize the end of the message. In the Arduino code, each value 
of each parameter is converted to its real equivalent. The message is sent when the “Start 
stimulation” button is pressed.  This message composes the data saved in a text file whenever 
the user choses to record the stimulus data. 
Additionally, a string message is sent from Arduino to LabVIEW since the user first press 
the “Start stimulation” button until stops the program. The string is solely composed by a digit 
(“%01d) which represent the stimulation pattern being executed (0 in case of no stimulation). 
In LabVIEW code, the string is read used to control how long the LED associated to the selected 
stimulation button needs to be on – when the first digit change its value, e.g. from 1 to 3, it 
means that the LED in the Single twitch button becomes off and the LED in the Tetanus button 
turns on.  
Table 3.1 summarizes all options inside the Ring Menus on Interface in the stimulus settings 
section. 
 
Table 3.1 - Setting parameters and corresponding options. 
  
The highlighted values (in bold) are the standards, or the most used values in the clinical 
practice. All the others were added for research purposes still being under development. 
Although the standard pulse duration is 200 µs, early in the days the typical applied pulse width 
was 300 µs. In the interface, the default values are the highlighted ones. In case a parameter 
has more than one standard value, it is assumes as default only one of them. 
 
  
Setting parameters Options 
Single Twitch Frequency (Hz) 0,1 – 0,2 – 0,5 – 1 – 2 
TOF Frequency (Hz) 0,5 – 1 – 2 
Tetanus Frequency (Hz) 50 – 60 – 70 – 80 – 90 – 100 – 110 – 120 
PTC first burst Frequency (Hz) 50 – 60 – 70 – 80 – 90 – 100 – 110 – 120 
PTC second burst Frequency (Hz) 0,1 – 0,2 – 0,5 – 1 – 2 
TOF-TOF interval 10 s – 20 s – 30 s – 1 min – 2 min – 5 min – 10 min 
PTC twitches 10 – 15 – 20 – 25 – 30 
Pulse duration (µs) 200 – 250 – 300 
Current (mA) 5 – 10 – 15 – 20 – 25 – 30 – 35 – 40 – 45 – 50 – 55 – 60 
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3.2 – Arduino programming 
 
The Arduino Uno was the chosen microcontroller to control the digital potentiometer and 
the digital switch. Moreover, Arduino and LabVIEW will exchange data between each other 
through serial communication to allow the user to, by simply interacting with the interface, 
control the system operation. This exchanged data between both platforms is maintained used 
a serial connection. For this matter, NI-VISA was used to configure the communication in the 
LabVIEW platform, while the same parameters were implemented in the Arduino board (Table 
3.2). 
 
 
The Arduino communicates with the AD5241 digital potentiometer through the I2C bus 
protocol, described in Annexes.  
Figure 3.10 summarizes the Arduino code structure. 
As mentioned in Chapter 3, the received message from LabVIEW is parsed until the 
termination character is found, and each value is associated to a variable. Thereafter, each 
variable assumes its initial value by a conversion function. Posteriorly, knowing the desired 
output current, it is determined the corresponding wiper value by applying equation 2.3, and 
sent to the digital potentiometer. Then, each stimulation pattern is programmed accordingly 
to its definition and is stored in its own function. the following example represents how the 
Single twitch function is designed. The input parameters are the frequency, freq_st, the pulse 
duration, width, and the variable previous initialised to millis() immediately before the single 
Twitch function is called in loop. The variable st is the signal period in milliseconds. The stimuli 
representation on the right demonstrate the stages of formation of a twitch. 
 
 
 
 
 
 
Table 3.2 – Serial communication settings. 
 
Serial parameters Options 
Baud rate (bit/s) 115200 
Data bits 8 
Enable termination char Yes 
Termination char /r /n 
Timeout (ms) 4 
Parity none 
Stop Bits 1 
Flow Control none 
Resource name COM3 (Arduino default) 
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int singleTwitch (unsigned long previous, int width, int freq_st) { 
   
  double st = 1000 / freq_st; 
 
  if (millis() - previous < (st - width)) { 
    digitalWrite(stimulus, LOW); 
  } 
  if (millis() - previous >= (st - width) && ((millis() - previous) <= st)) { 
    digitalWrite(stimulus, HIGH); 
  } 
  if (millis() - previous >= st) { 
    previous = millis(); 
  } 
  return 1; 
} 
 
 
The pattern function returns an int which is sent as message to LabVIEW. As 
aforementioned, this value is important to control the LEDs in the user interface. When the 
message from LabVIEW is sent to Arduino, the LED of the selected stimulation pattern turns 
on. Depending on the pattern, its function in Arduino will return 0 or not. In case of patterns 
that are not cyclic – Tetanus, PTC, DBS 3-3, DBS 2-3, DBS 3-2 – when their function is executed, 
return 0, which is sent to LabVIEW and means that the stimulus finished and so the 
corresponding LED must turn off. In case of Single twitch and TOF, which are both cyclic, their 
functions return its corresponding value (1 for Single Twitch, and 2 for TOF). It means that the 
LED remain on until other stimulus is selected. 
 
In the case of Tetanus and PTC, which are the most severe stimulation patterns due to a 
prolonged high frequency stimulation, was defined a period of 3 min in which, at the end of 
stimulus, the signal become low. It guarantees that no other stimulus is transmitted to the 
patient until that period of no stimulation is finished. It is crucial because, as already 
mentioned in Chapter 1, after a tetanus occurs post-tetanic facilitation, a phenomenon which 
lasts for 3 min, and can lead to overestimation of the extent of NM recovery. 
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Process 
Labview 
message 
Establish 
connection 
Arduino -
AD5241 
Figure 3.10 – Scheme of the Arduino code structure. 
SETUP FUNCTION 
Initialise I2C communication as master 
Initialise serial communication 
Start I2C communication 
Send command byte 
Stop I2C communication 
Configure output and input pins 
Initialise variables 
Include libraries 
Define name of input and output pins 
Define digital potentiometer’s I2C address 
Declare variables 
Parse string 
Match each field to corresponding variable 
Map acquired value to its real value 
Determine wiper value 
Start I2C communication 
Select data register 
Send wiper value byte 
Stop I2C communication 
Is number of bytes> 0 
Yes 
Read message sent by Labview 
No 
Call function of the chosen stimulation pattern 
Process 
Labview 
message 
Control 
AD5241 
resistance 
LOOP FUNCTION 
Send message to LabVIEW  
Send signal to the digital switch 
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Chapter 4: Results and Discussion 
Figure 4.1 illustrates the full system setup, comprising the components referred before. 
The corresponding schematic, designed on Eagle, is presented in Figure 4.2. 
 
The circuit must be capable of providing the correct signals when the user choses a 
stimulation pattern in the interface by pressing the correspondent button. Moreover, the signal 
must accomplish all specifications defined by the user, namely the output current, the signal 
frequency and other parameters specific for certain stimulation patterns. 
In the analysis of the results, the measured signal output current and the characteristics 
for each pattern are presented. 
  
Figure 4.1 - Electronic circuit. 
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Figure 4.2 - Eagle schematic of the electronic circuit. 
 
By selecting in the interface the desired current value, it was possible to compare the 
expected value with the measured output. The current was measured using the multimeter, 
whose probes were placed in series with the output signal of the digital switch. Table 4.1 
contains the registered electrical current data. The experimental data results are similar to 
the expected values, with an average error of 1.18%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Output signal 
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Table 4.1 - Expected and measured current values. 
Expected current (mA) Measured current (mA) 
60 59,67 
55 54,72 
50 49,65 
45 44,70 
40 39,74 
35 34,77 
30 29,81 
25 24,82 
20 19,74 
15 14,77 
10 9,80 
5 4,79 
Average error (%) 1,18 
  
Next, each obtained signal will be compared to the corresponding stimulation pattern. The 
following images were acquired through the oscilloscope. For visualization purposes, the pulse 
width was set to 10 ms. 
 
Single Twitch 
 
Single twitch pattern (see Figure 1.2) is the most simple stimulation pattern, being typically a 
periodic 0.1 or 1Hz squared wave. Figure 4.3 shows a single twitch signal set to 1 Hz. 
Figure 5.3 - Single twitch signal. 
Figure 4.3 - Single twitch signal. 
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TOF 
 
TOF (see Figure 1.3) is described as a set of 4 stimulus at 1 Hz separated from the next 4 
stimulus for a predetermined interval. In Figure 4.4 is shown a TOF signal at 1 Hz, 10 s separated 
from the next TOF stimulus. To verify if the aforementioned interval is accomplished, it was 
used the cursor tool of the oscilloscope. Cursor A was placed in the end of the first TOF last 
stimuli and the cursor B in the beginning of the second TOF first stimuli (Figure 4.5). Such 
interval is achieved. 
Figure 4.4 - TOF signal. 
Figure 4.5 - Measurement of the temporal distance between two TOFs. 
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Tetanus 
 
Tetanus (see Figure 1.9) is defined by a set of 50 Hz stimulus for 5 s. It was chose a 
frequency equal to 50 Hz, and Figure 4.6 shows that the signal is at the specified frequency. 
The time scale of the zoomed image of the signal is 50,0 ms. Figure 4.7 confirms that the 
signal has a 5 s duration. 
 
 
 
Figure 4.6 - Tetanus signal. 
Figure 4.7 - Measurement of the tetanus stimulus duration. 
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PTC 
 
PTC (see Figure 1.8) is constituted by two different types of signal: first burst is a tetanus 
and the second burst is a set of single twitches. Both bursts are 3s distant. The chosen number 
of twitches was 10. As can be seen in Figure 4.8, the signal is correctly performed: the tetanus 
is 5 s long, there is a time delay of 3 seconds between each burst, and thereafter, 10 single 
twitches at 1 Hz as chosen. 
 
DBS 3-3 
 
DBS 3-3 (see Figure 1.4) is composed by two bursts of three 50Hz pulses each, with a 750 
ms time interval between the beginning of the first and second bursts. The signal presented on 
Figure 4.9 shows a correct frequency and number of pulses in each burst. Figure 4.10 confirms 
the interval between bursts, by the use of cursors A and B, placed in the beginning of both 
bursts.   
Figure 4.8 - PTC signal. 
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DBS 2-3 
 
DBS 2-3 comprises 2 bursts, being the first one composed by two 50 Hz pulses and the 
second by three 50 Hz pulses. The second burst starts 750 ms after the beginning of the first 
burst. Figure 4.11 shows the resultant signal. Besides the correct frequency and number of 
pulses in each burst, it is verified the time distance between bursts (Figure 4.12).   
 
Figure 4.9 - DBS 3-3 signal. 
Figure 4.10 - Measurement of the temporal distance between the first and second bursts in the DBS 3-3 
signal. 
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Figure 4.11 - DBS 2-3 signal. 
  
Figure 4.12 - Measurement of the temporal distance between the first and second bursts in the DBS 2-3. 
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DBS 3-2 
 
DBS 3-2 is similar to DBS 2-3 but in the first burst instead of 2 pulses it has 3, and in the 
second burst instead of 3 pulses it has 2. Figure 4.13 shows the resultant signal, which achieves 
all conditions, including the time interval (Figure 4.14).  
  
Figure 4.13 - DBS 3-2 signal. 
Figure 4.14 - Measurement of the temporal distance between the first and second bursts in the DBS 3-2 
signal. 
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Chapter 5: Conclusions 
Neuromuscular monitoring is of great clinical interest since provides to anaesthetists a 
better assessment of NMB degree. Independently of the chosen stimulation pattern, clinical 
care will be improved if such monitoring is implemented.  
It has been proven that usage of reversal agents do not guarantee a complete elimination 
of PORC. Likewise, intraoperative use of neuromuscular monitoring allows the anaesthetist to 
use an adequate dosage of muscle relaxants and antagonists during surgeries.  
Although deep NMB can improve conditions for some surgical procedures, it is also more 
associated to the presence of PORC in patients and so monitoring can be of major importance 
in these cases.  
Clinical studies have shown that patients’ muscles responses differ accordingly to the 
frequency of stimuli. However, current peripheral nerve stimulators deliver range limited 
stimuli, and do not process the obtained results, impairing an appropriate evaluation of NMB, 
as observed by the student in visits to the operating room of Centro Hospitalar do Porto. 
The presented device do not accomplishes all the requirements of the ideal system, yet, is 
able to overcome the detected drawbacks of existent stimulators, providing a personalized 
stimulation to the patient. Current is correctly controlled and stimulus characteristics are 
according to the described in literature. Moreover, the interface is intuitive and of easy 
operation.  
This dissertation is also part of an ongoing pipeline of development, and therefore provide 
a starting platform for more precise and accurate research in the NMB field. 
 
Future work: 
 
Next stages of the work tackle the implementation a customized current source, the 
determining of patient’s skin resistance to inform the anesthetist if it is necessary to permeate 
the skin where the electrodes are placed, and posterior realization of clinical tests. It is 
expected that the upgraded system will decrease the incidence of PORC, the administered 
doses of NMBD and reversals, the recovery time, and surgeries cost. 
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Annexes 
I2C communication protocol 
 
I2C Bus definition 
 
A bus system is a communication path required by two or more devices to transmit and 
receive information between them. An I2C (Inter-integrated Circuit) bus is a bidirectional two-
wired serial bus which is used to transport the data between integrated circuits. It consists of 
two signal lines: SCL and SDL, which are used to communicate with the devices. SCL (Serial 
Clock Line) is used to synchronize all data transferred over the I2C bus. SDL (Serial Data Line) 
is driven by either the master or the slaves (or I2C peripherals). The SCL and SDA lines are 
connected to all devices in the I2C bus. Moreover, they are in open-drain state when there is 
no transfer between I2C peripherals. In other words, saying that the SDL and SCL pins of the 
master device are with the transistors in open state means that they can pull a signal line low, 
but are unable to drive it high. Hence, these lines are connected through pull-up resistors to 
VCC, to go high when no other signal is pulling it low. As the used Arduino’s main chip is the 
Atmel ATmega328p, which contains internal pull-up resistors, no external pull-up resistors are 
needed [62][63]. 
 
Masters and slaves 
 
The devices on the I2C bus are either masters or slaves. The master is the device that drives 
the SCL clock line and is the one that can initiate a transfer over the I2C bus. The slaves are 
the devices that respond to the master. Both master and slave can transfer data over the I2C 
bus, but controlled by the master. In this project, the master is the microcontroller – the 
Arduino Uno – and the slave is the digital potentiometer – AD5241. 
 
I2C Addresses 
 
An I2C slave device has a unique 7-bit address on the bus. It means that is possible to have 
up to 128 devices, since a 7 bit number can be from 0 to 127. When sending out the 7 bit 
address, it is always sent an extra bit – the R/W bit – used to inform the slave if the master is 
writing to it (bit 0) or reading from it (bit 1). The 7 bit address is placed in the upper 7 bits of 
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the byte and the R/W bit is in the LSB [64]. The 5 MSBs (Most Significant Bits) are 01011 and 
the following two bits are determined by the state of the AD0 and AD1 pins. In the circuit, AD0 
and AD1 are connected to ground, assuming the logic value of 0. Figures 1 and 2 are a guidance 
to better understand the I2C communication description. 
Figure 1 - Writing to the AD5241 serial register [60]. 
Figure 2 - Reading Data from the AD5241 register in write mode [60]. 
 
I2C Protocol 
 
The normal state is characterized by both lines being high. The master device initiates the 
communication sending out a start sequence. This step starts when a high-to-low transition on 
the SDA line occurs while SCL is still high. The first byte is the Frame 1, a slave address byte 
that, as aforementioned, consists of a 7-bit slave address followed by the R/W bit. 
The slave device recognises the transmitted address, pulls the SDA line low during the ninth 
clock pulse – the acknowledge bit. The device waits for data to be written to or read from its 
serial register.  
The write operation contains one more byte than the read operation – the Frame 2 
instruction byte. The first MSB is labelled A/B and is set low. The second MSB, RS, is the 
midscale reset; a logical high of the bit moves the wiper to the centre where RWA = RWB. The 
third MSB, SD, is a shutdown bit; a logic high causes an open circuit at Terminal A while the 
wiper to Terminal B is shorted, yielding almost a 0 Ω rheostat. The next two bits are O2 and O1, 
extra programmable logic outputs that can be manipulated by the user to drive other digital 
loads. The last 3 LSBs are “don’t care”.  
After the instruction byte in write mode, starts the Frames 3 data byte. Data is transmitted 
over the serial bus in sequences of nine clock pulses – 8 data bits and an acknowledge bit. 
Transitions on the SDA line occur during the low period of SCL and remain steady during the 
high period of SCL. 
In the read mode, the data byte – Frame 2 – flows instantly after the acknowledgment of 
the slave address byte. Data is transmitted over the serial bus in sequences of nine clock pulses 
– 8 data bits and a no acknowledge Logic 1 bit. Alike the write mode, transitions on the SDA 
line must occur during the high period of SCL. 
After the successive transmission of all data, the master generates a stop condition. It is 
characterized by a low-to-high transition on the SDA line while SCL is high. To define the stop 
condition in the write mode, the master pulls the SDA line high during the tenth clock pulse. 
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In read mode, the SDA line remains high during the ninth clock pulse and then brings the SDA 
line low before the tenth clock pulse where goes high to define a stop condition. 
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